News Centre

Boehringer Ingelheim News Centre

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

back 1 2 3 4 5 6 7 8 9 10 next

26.01.2012	Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib* - For non-US Media Only
26.01.2012	Boehringer Ingelheim launches ‘Lean-to-Clinic’ program for fast drug product supply
07.12.2011	Winners of the Making More Health competition bring fresh innovation to solving problems in health
01.12.2011	Boehringer Ingelheim and AVEO Pharmaceuticals announce manufacturing agreement for ficlatuzumab
17.11.2011	Boehringer Ingelheim's Anticoagulant PRADAX® Awarded Prestigious Prix Galien Canada for Most Innovative Product in 2011
08.11.2011	BI 201335 demonstrates potential to shorten HCV treatment duration while achieving high sustained virological response rates in difficult to treat patients ^1,2 - For media outside the US only
07.11.2011	Hepatitis C: Interferon-free combination of BI 201335 plus BI 207127 and ribavirin shows up to 76% of patients achieve a virological response at week 12, and 59% achieve SVR12 with 16 weeks treatment ¹
03.10.2011	Health Canada approves Trajenta™ (linagliptin) for the treatment of type 2 diabetesFirst DPP-4i that does not require a dosage adjustment for patientswith mild to moderate renal impairment
29.09.2011	Health Canada Approves TWYNSTA™, the First and Only ARB / CCB Single Pill Combination Therapy of its Kind for Effective Hypertension Control
26.09.2011	Boehringer Ingelheim expands its Business with Biosimilars

back 1 2 3 4 5 6 7 8 9 10 next

Visit our corporate website for more information on Boehringer Ingelheim.

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.